Skip to main content
Premium Trial:

Request an Annual Quote

FDA Approves Allergan's Cell-based Assay for Botox

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Allergan announced late on Friday that the US Food and Drug Administration has approved its in vitro, cell-based assay for use in the stability and potency testing of Botox and Botox Cosmetic, possibly eliminating the need for animal-based testing of the treatment.

The approved assay will be used immediately on Botox products sold in the US, Allergan said. It added that as other regulatory agencies worldwide approve the assay, it could reduce the use of animal-based testing for Botox products by up to 95 percent or more during the next three years.

The assay is the first to be developed and approved for any botulinum neurotoxin currently available worldwide, and is specifically applicable to Allergan's botulinum toxin type A product.

"Following the FDA approval, we will work hard to secure approval of the new assays to replace the current animal testing requirements for the release and stability testing of Botox and Botox Cosmetic in countries in which we market and distribute the product," Scott Whitcup, Allergan's executive vice president of R&D and chief scientific officer, said in a statement.

Approval of the assay by FDA follows more than a decade of R&D at Allergan and an investment of about $65 million to minimize the need for animal-based testing for Botox products, the company said.

"The new cell-based potency assay we have developed for Botox and Botox Cosmetic has many advantages over current methods, including the potential for greater precision and consistency in stability and potency testing, making this a significant breaththrough in both the science and manufacturing of neurotoxins," said Timothy Terrell, senior vice president of drug safety evaluation for Allergan.

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.